92 related articles for article (PubMed ID: 1345822)
21. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.
Weston A; Ling-Cawley HM; Caporaso NE; Bowman ED; Hoover RN; Trump BF; Harris CC
Carcinogenesis; 1994 Apr; 15(4):583-7. PubMed ID: 7908608
[TBL] [Abstract][Full Text] [Related]
22. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.
Nau MM; Brooks BJ; Battey J; Sausville E; Gazdar AF; Kirsch IR; McBride OW; Bertness V; Hollis GF; Minna JD
Nature; 1985 Nov 7-13; 318(6041):69-73. PubMed ID: 2997622
[TBL] [Abstract][Full Text] [Related]
23. Increased metastasis with loss of E2F2 in Myc-driven tumors.
Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER
Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282
[TBL] [Abstract][Full Text] [Related]
24. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
Bièche I; Champème MH; Lidereau R
Cancer Res; 1994 Aug; 54(16):4274-6. PubMed ID: 7913873
[TBL] [Abstract][Full Text] [Related]
25. [Close correlation between restriction fragment length polymorphism of the L-myc gene and metastasis of lung cancer and prognosis].
Kawashima K; Nishimura S
Rinsho Byori; 1989 Jul; (Spec No 82):29-34. PubMed ID: 2575676
[No Abstract] [Full Text] [Related]
26. Correlation of L-myc genotypes to metastasis of gastric cancer and breast cancer.
Ishizaki K; Kato M; Ikenaga M; Honda K; Ozawa K; Toguchida J
J Natl Cancer Inst; 1990 Feb; 82(3):238-9. PubMed ID: 1967321
[No Abstract] [Full Text] [Related]
27. Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients.
Ejarque MJ; Vicente M; Bernués M; Oliver A; Vicente J; Capellá G; Lluís F; Chéchile G
Br J Cancer; 1999 Apr; 79(11-12):1855-8. PubMed ID: 10206304
[TBL] [Abstract][Full Text] [Related]
28. EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer.
Rubio SA; Martinez SE; Corona JS; Ruiz AP; Rincon AE; Lagunas IA; Camacho JG; Moguel MC
Breast Cancer Res Treat; 2006 Mar; 96(2):159-61. PubMed ID: 16317582
[TBL] [Abstract][Full Text] [Related]
29. Restriction fragment length polymorphisms of the human N-myc gene in normal healthy individuals and oral cancer patients in India.
Saranath D; Panchal RG; Deo MG; Sanghvi V; Mehta AR
Indian J Biochem Biophys; 1994 Jun; 31(3):177-83. PubMed ID: 7959843
[TBL] [Abstract][Full Text] [Related]
30. L-myc gene polymorphism and risk of thyroid cancer.
Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
[TBL] [Abstract][Full Text] [Related]
31. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R; Har YC; Taib NA
J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
[TBL] [Abstract][Full Text] [Related]
32. An EcoRI RFLP downstream of the human c-myc gene.
Yamamoto K; Lin HF; Yamashita M; Miyoshi N; Tojo A; Shibuya M
Nucleic Acids Res; 1991 Dec; 19(24):6973. PubMed ID: 1684853
[No Abstract] [Full Text] [Related]
33. Rflp analysis of the L-myc oncogene in head and neck-cancer - relationship study with susceptibility and disease progression.
Millon R; Muller D; Velten M; Doffoel S; Eber M; Engelmann A; Bronner G; Flesch H; Methlin G; Abecassis J
Int J Oncol; 1995 Jan; 6(1):237-42. PubMed ID: 21556529
[TBL] [Abstract][Full Text] [Related]
34. Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen CJ
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7068-70. PubMed ID: 2996003
[TBL] [Abstract][Full Text] [Related]
35. Analysis of genetic alterations related to the development and progression of breast carcinoma.
Nagayama K; Watatani M
Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963
[TBL] [Abstract][Full Text] [Related]
36. A single point mutation responsible for c-mos polymorphism in cancer patients.
Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
[TBL] [Abstract][Full Text] [Related]
37. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
38. [Association between H-ras and L-myc gene polymorphisms and susceptibility to colorectal cancer].
Ni Q; Zhang YJ; Zhang SC; Jin MJ; Ma XY; Yao KY; Li QL; Chen K
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):15-20. PubMed ID: 22490849
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
Spinola M; Pedotti P; Dragani TA; Taioli E
Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
[TBL] [Abstract][Full Text] [Related]
40. Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patients.
Spinola M; Nomoto T; Manenti G; Falvella FS; Brega Massone PP; Conti B; Cataldo I; Valagussa P; Incarbone M; Miyamoto K; Ushijima T; Dragani TA
Int J Cancer; 2001 Sep; 95(5):329-31. PubMed ID: 11494234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
